dbo:abstract
|
- Ludwig Norbert Michel Hantson (nacido en agosto de 1962) es un empresario belga, es el CEO de Alexion Pharmaceuticals desde marzo de 2017. Fue presidente y director ejecutivo de Baxalta, compañía biofarmacéutica estadounidense, desde 2015 a 2016. (es)
- Ludwig Norbert Michel Hantson (born August 1962) is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017. He was the president and CEO of Baxalta, an American biopharmaceutical company, from 2015 to 2016. (en)
|
dbo:birthName
|
- Ludwig Norbert Michel Hantson (en)
|
dbo:knownFor
| |
dbo:personFunction
| |
dbo:title
|
- CEO,Alexion Pharmaceuticals (en)
|
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 3417 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:almaMater
| |
dbp:birthName
|
- Ludwig Norbert Michel Hantson (en)
|
dbp:knownFor
|
- former president and CEO, Baxalta (en)
|
dbp:name
| |
dbp:nationality
| |
dbp:title
|
- CEO, Alexion Pharmaceuticals (en)
|
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Ludwig Norbert Michel Hantson (nacido en agosto de 1962) es un empresario belga, es el CEO de Alexion Pharmaceuticals desde marzo de 2017. Fue presidente y director ejecutivo de Baxalta, compañía biofarmacéutica estadounidense, desde 2015 a 2016. (es)
- Ludwig Norbert Michel Hantson (born August 1962) is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017. He was the president and CEO of Baxalta, an American biopharmaceutical company, from 2015 to 2016. (en)
|
rdfs:label
|
- Ludwig N. Hantson (en)
- Ludwig N. Hantson (es)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:keyPerson
of | |
is dbo:wikiPageDisambiguates
of | |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is dbp:keyPeople
of | |
is foaf:primaryTopic
of | |